“…A similar 31 P NMR spectroscopic behavior has been reported for compounds [{(η 6 ‐ p ‐cymene)RuClN 3 } 2 (μ 2 ‐dppe)] [ δ = 26.7 (d)],7a [{(η 6 ‐C 6 Me 6 )RuXN 3 } 2 (μ 2 ‐dppe)] [X = N 3 , δ = 31.1],7b [X = Cl, δ = 30.3],7b [(η 6 ‐C 6 H 6 )RuCl 2 ] 2 (μ 2 ‐dppe) [ δ = 23.3 (s)],7c [{CpRu(N 3 )} 2 (μ 2 ‐dppe) 2 ] [ δ = 39.19],8a [{CpRuCl} 2 (μ 2 ‐dppe) 2 ] [ δ = 37.10],8a and [{CpRu(SnCl 3 ) 2 } 2 (μ 2 ‐dppe)] [ δ = 43.5 (s)],8b as well as three intermediates species observed in the phosphine substitution reactions between CpRuCl(PPh 3 ) 2 and dppe: CpRuCl(PPh 3 )(κ 1 ‐dppe) [ δ = 41.51 (d), –12.10],8a CpRuCl(κ 1 ‐dppe) 2 [ δ = 40.72 (d), –12.31],8a and [{CpRuCl(PPh 3 )} 2 (μ 2 ‐dppe)] [ δ = 43.11 (d), 42.76 (d)] 8a. In agreement with the presence of a bridging dppe ligand in compound 5 , the 31 P NMR shows an upfield shift compared to complexes where the dppe is acting as a chelate in mononuclear ruthenium derivatives, such as: [(η 6 ‐C 6 H 6 )Ru(κ 2 ‐dppe)Cl]Cl [ δ = 70.4 (s)],7c CpRuCl(κ 2 ‐dppe) [ δ = 79.9],9 [CpRu(L)(κ 2 ‐dppe)]BPh 4 [ δ = 78.3–82.9],9 Cp*RuX(κ 2 ‐dppe) [X = Cl, δ = 73.5–74.6],10,11 [X = N 3 , δ = 75.7],11 [X = H, δ = 90.2],12 [Cp*RuX(κ 2 ‐dppe)]BF 4 [X = (H) 2 , δ = 71.3, (η 2 ‐H 2 ), δ = 77.4],12 and CpRu(κ 2 ‐dppe)SnCl 3 [ δ = 77.8 (s)],8b or dinuclear compounds where the bidentate dppe is also coordinated only to one metal atom, such as {Cp(PPh 3 ) 2 Ru}C≡C‐C≡C{Ru(κ 2 ‐dppe)Cp} δ = 86.1 and {Cp(κ 2 ‐dppe) 2 Ru}C≡C‐C≡C{Ru(κ 2 ‐dppe)Cp} δ = 86.7 ppm 13…”